NOV 08, 2021 9:00 AM PST

A case study of CBD's tumor shrinking potential

WRITTEN BY: Kerry Charron

A recent article published in the British Medical Journal reported the case of a woman who shrank a tumor by taking CBD. Serial imaging shows the tumor decreased from 41 to 10 millimeters in just 2.5 years. The patient took .5ml of CBD oil two or three times a day. She declined conventional lung cancer treatments which usually involve chemotherapy, surgery, and radiotherapy and opted for following this specific CBD dosing schedule. This case study and other trial tests suggest cannabidiol oil may be highly effective in reducing the overall size of certain types of tumors.

CBD has been widely used for symptoms such as insomnia and anxiety, but emerging research data highlights potential therapeutic uses for oncology patients. Specifically, CBD can provide tumor management as well as reduction of other symptoms such as nausea and discomfort. Patient anecdotal evidence highlights many therapuetic benefits of CBD, but recent research attention has focused on how CBD impacts cancerous cell growth.

Studies on brain tumors conducted by University of Leeds researchers indicate that cannabis oil can reduce aggressive cancerous growth. Phase I of the trial test determined that CBD has anti-tumor properties. Phase II of this trial test will involve 15 National Institute of Health hospitals. 223 study participants will self-administer an oromucosal spray which consists of a 1:1 CBD to THC ratio up to 12 sprays per day. Participants will be asked to complete a quality-of-life questionnaire in addition to monthly medical checkups. This study will be one of the first trials to integrate with BRIAN, an app supporting those living with a brain tumor.

Phase II will examine the effects of adding Sativex to the current standard chemotherapy treatment (temozolomide) on the survival time for adults with glioblastoma. Glioblastoma is the most common type of brain tumor in adults, and it is characterized by fast growth and formations that are tendril-like. Recurring growth after surgery or radiation therapy is common, and the survival time after diagnosis is roughly 12-18 months. Researchers are hopeful that this study will lead to advances in CBD use for tumor regression, improved quality of life, and life extension for those living with brain cancer tumors. 

 

Sources: British Medical JournalUniversity of LeedsNature

About the Author
  • Kerry Charron writes about medical cannabis research. She has experience working in a Florida cultivation center and has participated in advocacy efforts for medical cannabis.
You May Also Like
NOV 09, 2021
Microbiology
Can This Cat Parasite Become a Tumor Treatment?
NOV 09, 2021
Can This Cat Parasite Become a Tumor Treatment?
You may have heard of Toxoplasma gondii because it is so common. Cats carry this parasite, and anyone that cleans a litt ...
NOV 18, 2021
Cannabis Sciences
Could Cannabis-Based Compounds Be the Next New Class of Antibiotics?
NOV 18, 2021
Could Cannabis-Based Compounds Be the Next New Class of Antibiotics?
According to the Centers for Disease Prevention and Control (CDC), antibiotic-resistant bacterial or fungal strains infe ...
NOV 22, 2021
Microbiology
Researchers Solve the Structure of the HIV Capsid, May Be a New Drug Target
NOV 22, 2021
Researchers Solve the Structure of the HIV Capsid, May Be a New Drug Target
Though treatments are available, there is no cure or vaccine from HIV, which impacts about 38 million people worldwide. ...
NOV 23, 2021
Infographics
The Health Benefits of Cannabis
NOV 23, 2021
The Health Benefits of Cannabis
Legislation is opening more and more doors for cannabis- causing an explosion in both research and marketing campaigns f ...
DEC 08, 2021
Drug Discovery & Development
Nighttime eating and circadian misalignment leads to glucose intolerance
DEC 08, 2021
Nighttime eating and circadian misalignment leads to glucose intolerance
It might be best to think twice before reaching for that midnight snack. A recent research report published in ...
JAN 01, 2022
Cannabis Sciences
Pharmacological Effects of Cannabis: To Be or Not To Be... Carboxylated?
JAN 01, 2022
Pharmacological Effects of Cannabis: To Be or Not To Be... Carboxylated?
Results from a new study published in Nature’s Scientific Reports suggest that the carboxylated (i.e., acidic) for ...
Loading Comments...